The calcification of adamantinomatous craniopharyngioma (ACP) often creates difficulties for surgical therapy. Nevertheless, the mechanism of ACP calcification is unclear. Our previous studies demonstrated that osteoblastic factors might play important roles in ACP calcification.
OBJECTIVE:
We examined the effects of recombinant human Bmp2 on ACP cell differentiation by testing osteoblastic proteins and calcium deposition.
METHODS:
The expression of osteoblastic factors including osteopontin (OPN), Runx2, and osterix in Bmp2-treated ACP cells was examined by western blot and/or real time PCR. ALP activity and calcium deposition after Bmp2 induction were also tested.
RESULTS:
Bmp2 significantly amplified the expression of Runx2, Osterix and OPN, as well as ALP activity. Both of these effects could be repressed by noggin treatment. Bmp2 also significantly induced the calcification of ACP, and noggin inhibited this calcium deposition.
CONCLUSION:
Our study demonstrated for the first time that ACP cells could differentiate into an osteoblastic lineage via induction by Bmp2. The mechanism of ACP calcification likely involves osteoblastic differentiation modulated by Bmp2. Further studies targeting Bmp2 cascades could result in novel therapeutic interventions for recurrent ACP.
Fernandez-MirandaJ.C., GardnerP.A., SnydermanC.H., DevaneyK.O., StrojanP., SuarezC., GendenE.M., RinaldoA. and FerlitoA., Craniopharyngioma: a pathologic, clinical, and surgical review, Head Neck34 (2012), 1036-44.
2.
KatoK., NakataniY., KannoH., InayamaY., IjiriR., NagaharaN., MiyakeT., TanakaM., ItoY., AidaN., TachibanaK., SekidoK. and TanakaY., Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma, J Pathol203 (2004), 814-21.
3.
SekineS., TakataT., ShibataT., MoriM., MorishitaY., NoguchiM., UchidaT., KanaiY. and HirohashiS., Expression of enamel proteins and LEF1 in adamantinomatous craniopharyngioma: evidence for its odontogenic epithelial differentiation, Histopathology45 (2004), 573-9.
4.
BeatyN.B. and AhnE., Images in clinical medicine. Adaman-tinomatous craniopharyngioma containing teeth, N Engl J Med370 (2014), 860.
5.
SatoK. and KubotaT., Fine structure of ossification in craniopharyngiomas, Ultrastruct Pathol23 (1999), 395-9.
6.
D'SouzaR.N., AbergT., GaikwadJ., CavenderA., OwenM., KarsentyG. and ThesleffI., Cbfa1 is required for epithelial-mesenchymal interactions regulating tooth development in mice, Development126 (1999), 2911-20.
7.
Begue-KirnC., SmithA.J., RuchJ.V., WozneyJ.M., PurchioA., HartmannD. and LesotH., Effects of dentin proteins, transforming growth factor beta 1 (TGF beta 1) and bone morphogenetic protein 2 (BMP2) on the differentiation of odontoblast in vitro, Int J Dev Biol36 (1992), 491-503.
8.
HoganB.L., Bone morphogenetic proteins: multifunctional regulators of vertebrate development, Genes Dev10 (1996), 1580-94.
9.
RileyE.H., LaneJ.M., UristM.R., LyonsK.M. and LiebermanJ.R., Bone morphogenetic protein-2: biology and applications, Clin Orthop Relat Res (1996), 39-46.
10.
KimM. and ChoeS., BMPs and their clinical potentials, BMB Rep44 (2011), 619-34.
11.
KatagiriT., YamaguchiA., IkedaT., YoshikiS., WozneyJ.M., RosenV., WangE.A., TanakaH., OmuraS. and SudaT., The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2, Biochem Biophys Res Commun172 (1990), 295-9.
12.
NoelD., GazitD., BouquetC., ApparaillyF., BonyC., PlenceP., MilletV., TurgemanG., PerricaudetM., SanyJ. and JorgensenC., Short-term BMP-2 expression is sufficient for in vivo osteochondral differentiation of mesenchymal stem cells, Stem Cells22 (2004), 74-85.
13.
LecandaF., AvioliL.V. and ChengS.L., Regulation of bone matrix protein expression and induction of differentiation of human osteoblasts and human bone marrow stromal cells by bone morphogenetic protein-2, J Cell Biochem67 (1997), 386-96.
14.
ThiesR.S., BauduyM., AshtonB.A., KurtzbergL., WozneyJ.M. and RosenV., Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells, Endocrinology130 (1992), 1318-24.
15.
RosenV., NoveJ., SongJ.J., ThiesR.S., CoxK. and WozneyJ.M., Responsiveness of clonal limb bud cell lines to bone morphogenetic protein 2 reveals a sequential relationship between cartilage and bone cell phenotypes, J Bone Miner Res9 (1994), 1759-68.
16.
TompkinsK., Molecular mechanisms of cytodifferentiation in mammalian tooth development, Connect Tissue Res47 (2006), 111-8.
17.
ChenS., Gluhak-HeinrichJ., WangY.H., WuY.M., ChuangH.H., ChenL., YuanG.H., DongJ., GayI. and MacDougallM., Runx2, osx, and dspp in tooth development, J Dent Res88 (2009), 904-9.
18.
HaraK., YamadaY., NakamuraS., UmemuraE., ItoK. and UedaM., Potential characteristics of stem cells from human exfoliated deciduous teeth compared with bone marrow-derived mesenchymal stem cells for mineralized tissue-forming cell biology, J Endod37 (2011), 1647-52.
19.
YangW., HarrisM.A., CuiY., MishinaY., HarrisS.E. and Gluhak-HeinrichJ., Bmp2 is required for odontoblast differentiation and pulp vasculogenesis, J Dent Res91 (2012), 58-64.
20.
KumamotoH. and OoyaK., Expression of bone morphogenetic proteins and their associated molecules in ameloblastomas and adenomatoid odontogenic tumors, Oral Dis12 (2006), 163-70.
21.
QiS.T., YanX.R., PanJ., DengY.J., LiangJ., HuangG.L., LuY.T., RuanJ., LiX.Z. and XuJ.M., Does the calcification of adamantinomatous craniopharyngioma resemble the calcium deposition of osteogenesis/odontogenesis?, Histopathology64 (2014), 336-47.
22.
QiS., HuangG., PanJ., LiJ., ZhangX., FangL., LiuB., MengW., ZhangY. and LiuX., Involvement of osteopontin as a core protein in craniopharyngioma calcification formation, J Neurooncol98 (2010), 21-30.
23.
LiQ., YouC., LiuL., RaoZ., SimaX., ZhouL. and XuJ., Craniopharyngioma cell growth is promoted by growth hormone (GH) and is inhibited by tamoxifen: involvement of growth hormone receptor (GHR) and IGF-1 receptor (IGF-1R), J Clin Neurosci20 (2013), 153-7.
24.
SabokbarA., MillettP.J., MyerB. and RushtonN., A rapid, quantitative assay for measuring alkaline phosphatase activity in osteoblastic cells in vitro, Bone Miner27 (1994), 57-67.
25.
CurranJ.G. and O'ConnorE., Imaging of craniopharyngioma, Childs Nerv Syst21 (2005), 635-9.
26.
KiehnaE.N., MulhernR.K., LiC., XiongX. and MerchantT.E., Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy, Journal of Clinical Oncology24 (2006), 5283-5290.
27.
DuffnerP.K., Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors, The neurologist10 (2004), 293-310.
28.
SrinivasanS., OgleG., GarnettS., BriodyJ., LeeJ. and CowellC., Features of the metabolic syndrome after childhood craniopharyngioma, The Journal of Clinical Endocrinology & Metabolism89 (2004), 81-86.
29.
HayashiY., KitaD., FukuiI., SasagawaY., OishiM., OkajimaM., TachibanaO. and NakadaM., Pediatric symptomatic Rathke cleft cyst compared with cystic craniopharyngioma, Child's Nervous System (2016), 1-8.
30.
WozneyJ.M., RosenV., CelesteA.J., MitsockL.M., WhittersM.J., KrizR.W., HewickR.M. and WangE.A., Novel regulators of bone formation: molecular clones and activities, Science242 (1988), 1528-34.
31.
ReddiA.H., Role of morphogenetic proteins in skeletal tissue engineering and regeneration, Nat Biotechnol16 (1998), 247-52.
32.
WangE.A., RosenV., D'AlessandroJ.S., BauduyM., CordesP., HaradaT., IsraelD.I., HewickR.M., KernsK.M., LaPanP. and EtA., Recombinant human bone morphogenetic protein induces bone formation, Proc Natl Acad Sci U S A87 (1990), 2220-4.
33.
PlikusM.V., Zeichner-DavidM., MayerJ.A., ReynaJ., BringasP., ThewissenJ.G., SneadM.L., ChaiY. and ChuongC.M., Morphoregulation of teeth: modulating the number, size, shape and differentiation by tuning Bmp activity, Evol Dev7 (2005), 440-57.
34.
SugiyamaO., AnD.S., KungS.P., FeeleyB.T., GamradtS., LiuN.Q., ChenI.S. and LiebermanJ.R., Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo, Mol Ther11 (2005), 390-8.
35.
ChengS.L., LouJ., WrightN.M., LaiC.F., AvioliL.V. and RiewK.D., In vitro and in vivo induction of bone formation using a recombinant adenoviral vector carrying the human BMP-2 gene, Calcif Tissue Int68 (2001), 87-94.
36.
NoheA., KeatingE., KnausP. and PetersenN.O., Signal transduction of bone morphogenetic protein receptors, Cell Signal16 (2004), 291-9.
37.
BanerjeeC., McCabeL.R., ChoiJ.Y., HiebertS.W., SteinJ.L., SteinG.S. and LianJ.B., Runt homology domain proteins in osteoblast differentiation: AML3/CBFA1 is a major component of a bone-specific complex, J Cell Biochem66 (1997), 1-8.
38.
NakashimaK., ZhouX., KunkelG., ZhangZ., DengJ.M., BehringerR.R. and de CrombruggheB., The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation, Cell108 (2002), 17-29.
39.
DucyP., ZhangR., GeoffroyV., RidallA.L. and KarsentyG., Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation, Cell89 (1997), 747-54.
40.
CaoZ., ZhangH., ZhouX., HanX., RenY., GaoT., XiaoY., de CrombruggheB., SomermanM.J. and FengJ.Q., Genetic evidence for the vital function of Osterix in cementogenesis, J Bone Miner Res27 (2012), 1080-92.
41.
OttoF., ThornellA.P., CromptonT., DenzelA., GilmourK.C., RosewellI.R., StampG.W., BeddingtonR.S., MundlosS., OlsenB.R., SelbyP.B. and OwenM.J., Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development, Cell89 (1997), 765-71.
